Here's your Thursday Thought Experiment: What i
Post# of 148112
What if the rumblings that the LH trial (which should have been well underway by now) has been delayed up to this point to coincide with an EUA for some reason? Maybe they're coming around to Leronlimab as their only hope in the short to mid term. They've been looking under the hood for approval and perhaps it's been helping to also fine tune the details surrounding the LH endpoints, data collection, etc.
For the record I think it's 100% unrelated but everything I own was down substantially today so I'm willing to bend reality to make myself feel better about it.